Prediction scores modified for use in patients with unprovoked VTE and simplified for daily clinical practice
Variable . | Modified ACCP . | Modified RIETE . | Modified VTE-BLEED . | Modified HAS-BLED . | Modified OBRI . |
---|---|---|---|---|---|
Age | >65 y, +1; >75 y, +2 | >75 y, +1 | ≥60 y, +1.5 | >65 y, +1 | >65 y, +1 |
Previous gastrointestinal bleed | +1 | – | +1.5 | +1 | +1 |
Renal insufficiency/failure | +1 | +1.5 | +1.5 | +1 | * |
Previous stroke | +1 | – | – | +1 | +1 |
Diabetes | +1 | – | – | – | * |
Anemia | +1 | +1.5 | +1.5 | – | * |
Antiplatelet therapy | +1 | – | – | +1 | – |
Nonsteroidal anti-inflammatory drug | +1 | – | – | – | |
Time in therapeutic INR range <60% | +1 | – | – | +1 | – |
Antihypertensive medication | – | – | Male, +1 | +1 | – |
Symptomatic pulmonary embolism | – | +1 | – | – | – |
Recent myocardial infarction | – | – | – | – | * |
Bleeding risk stratification | – | – | – | – | – |
Non–high risk | 0-1 risk factors | 0-4 points | 0-1 points | 0-2 points | 0-2 points |
High risk | ≥2 risk factors | ≥5 points | ≥2 points | ≥3 points | ≥3 points |
Variable . | Modified ACCP . | Modified RIETE . | Modified VTE-BLEED . | Modified HAS-BLED . | Modified OBRI . |
---|---|---|---|---|---|
Age | >65 y, +1; >75 y, +2 | >75 y, +1 | ≥60 y, +1.5 | >65 y, +1 | >65 y, +1 |
Previous gastrointestinal bleed | +1 | – | +1.5 | +1 | +1 |
Renal insufficiency/failure | +1 | +1.5 | +1.5 | +1 | * |
Previous stroke | +1 | – | – | +1 | +1 |
Diabetes | +1 | – | – | – | * |
Anemia | +1 | +1.5 | +1.5 | – | * |
Antiplatelet therapy | +1 | – | – | +1 | – |
Nonsteroidal anti-inflammatory drug | +1 | – | – | – | |
Time in therapeutic INR range <60% | +1 | – | – | +1 | – |
Antihypertensive medication | – | – | Male, +1 | +1 | – |
Symptomatic pulmonary embolism | – | +1 | – | – | – |
Recent myocardial infarction | – | – | – | – | * |
Bleeding risk stratification | – | – | – | – | – |
Non–high risk | 0-1 risk factors | 0-4 points | 0-1 points | 0-2 points | 0-2 points |
High risk | ≥2 risk factors | ≥5 points | ≥2 points | ≥3 points | ≥3 points |
1 point is scored for ≥1 comorbidity, including renal impairment, diabetes, anemia, or recent myocardial infarction.